Diagnosis of Heart Failure

Heart Failure Clinics

Volumn 5, Issue 1, 2009, Pages 25-35

  Chang, Anna Marie ^a   Maisel, Alan S ^b   Hollander, Judd E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BNP; Diagnosis of heart failure; Heart failure; Nt pro BNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DYSPNEA; ELECTROCARDIOGRAM; HEART FAILURE; HEART SOUND; HOSPITAL ADMISSION; HUMAN; IMPEDANCE CARDIOGRAPHY; MEDICAL RECORD; PHONOCARDIOGRAPHY; PHYSICAL EXAMINATION; RELIABILITY; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

BIOLOGICAL MARKERS; CARDIOGRAPHY, IMPEDANCE; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; ELECTROCARDIOGRAPHY; HEART FAILURE; HUMANS; MEDICAL HISTORY TAKING; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PHONOCARDIOGRAPHY; PHYSICAL EXAMINATION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRIAGE; TROPONIN I;

EID: 56049086009     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.08.013     Document Type: Review

References (70)

1. Hsieh M., Auble T.E., and Yealy D.M. Validation of the acute heart failure index. Ann Emerg Med 51 (2008) 37-44
2. Mueller C., Laule-Kilian K., Frana B., et al. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. Am Heart J 151 (2006) 471-477
3. Collins S., Storrow A.B., Kirk J.D., et al. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med 51 (2008) 45-57
4. Wang C.S., Fitzgerald J.M., Schulzer M., et al. Does this dyspneic patient in the emergency department have congestive heart failure?. J Am Med Assoc 294 (2005) 1944-1956
5. Wong G.C., and Ayas N.T. Clinical approaches to the diagnosis of acute heart failure. Curr Opin Cardiol 22 (2007) 207-213
6. Tsuyuki R.T., McKelvie R.S., Arnold J.M., et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161 (2001) 2337-2342
7. Levy D., Larson M.G., Vasan R.S., et al. The progression from hypertension to congestive heart failure. J Am Med Assoc 275 (1996) 1557-1562
8. Chen Y.T., Vaccarino V., Williams C.S., et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 106 (1999) 605-612
9. Chae C.U., Pfeffer M.A., Glynn R.J., et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 28 (1999) 634-639
10. Remes J, Miettinen H, Reunanen A, et al. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J;199(12):315-21.
11. Drazner M.H., Rame E., Stevenson L.W., et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345 (2001) 574-581
12. Drazner M.H., Hamilton M.A., Fonarow G., et al. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant 18 (1999) 1126-1132
13. Collins S.P., Lindsell C.J., Peacock W.F., et al. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea. J Card Fail 12 (2006) 286-292
14. Collins S.P., Lindsell C.J., Peacock W.F., et al. The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure. Am J Emerg Med 24 (2006) 25-32
15. Butman S.M., Ewy G.A., Standen J.R., et al. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 22 (1993) 968-974
16. Marcus G.M., Vessey J., Jordan M.V., et al. Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med 166 (2006) 617-622
17. Marcus G.M., Michaels A.D., De Marco T.D., et al. Usefulness of the third heart sound in predicting an elevated level of B-type natriuretic peptide. Am J Cardiol 93 (2004) 1312-1313
18. Ishmail A.A., Wing S., Ferguson J., et al. Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest 91 (1987) 870-873
19. Mangione S., and Neiman L.Z. Cardiac auscultatory skills of internal medicine and family practice trainees: a comparison of diagnostic proficiency. JAMA 278 (1997) 717-722
20. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
21. Chakko S., Woska D., Martinez H., et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90 (1991) 353-359
22. Binanay C., Califf R.M., Hasselblad V., et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the escape trial. J Am Med Assoc 294 (2005) 1625-1633
23. Collins S.P., Lindsell C.J., Abraham W.T., et al. The emergency department chest radiograph is unreliable in establishing a diagnosis of heart failure. J Card Fail 10 (2004) S30
24. Collins S., Lindsell C.J., Storrow A.B., et al. Prevalence of negative chest radiography in the emergency department patient with decompensated heart failure. Ann Emerg Med 47 (2006) 13-18
25. Middlekauff H.R., Stevenson W.G., and Stevenson L.W. Prognostic significance of a trial fibrillation in advanced heart failure: a study of 390 patients. Circulation 84 (1991) 40-48
26. Mathew J., Hunsberger S., Fleg J., et al. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118 (2000) 914-922
27. Maisel A.S., Krishnaswamy P., Nowak R.M., et al., Breathing Not Properly Multinational Study Investigators. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
28. Maisel A.S., McCord J., Nowak R.M., et al., Breathing Not Properly Multinational Study Investigators. Bedside b-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41 (2003) 2010-2017
29. McCullough P.A., Nowak R.M., McCord J., et al., for the BNP Multinational Study Investigators. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation 106 (2002) 416-422
30. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
31. Maisel A.S., Hollander J.E., Guss D., et al., Rapid Emergency Department Heart Failure Outpatient Trial Investigators. Primary results of the rapid emergency department heart failure outpatient trial (redhot): a multicenter study of b-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 (2004) 1328-1333
32. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type natriuretic peptide (BNP) predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39 (2002) 131-138
33. Shah M.R., Hasselblad V., Tasissa G., et al. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure. From the evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness trial. Am J Cardiol 100 (2007) 1427-1433
34. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
35. Moe G.W., Howlett J., Januzzi J.L., et al., Canadian Multicenter Improved Management of Patients with Congestive Heart Failure (improve-chf) Study Investigators. N-terminal pro-b-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter improve-chf study. Circulation 115 (2007) 3103-3110
36. LeJemtel T.H., Padeletti M., and Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49 (2007) 171-180
37. McCullough P.A., Hollander J.E., Nowak R.M., et al., BNP Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of b-type natriuretic peptide in the emergency department. Acad Emerg Med 10 (2003) 198-204
38. Wolde M., Tulevski II, Mulder J.W., et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 107 (2003) 2082-2084
39. Januzzi J.L., Van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The international collaborative of NT-proBNP study. Eur Heart J 27 (2006) 330-337
40. Wu A.H., Omland T., Duc P., et al., Breathing Not Properly Multinational Study Investigators. The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study. Diabetes Care 27 (2004) 2398-2404
41. O'Donoghue M., Kenney P., Oestreicher E., et al. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study). Am J Cardiol 100 (2007) 1336-1340
42. McCord J, Mundy BJ, Hudson MP, et al, for the BNP Multinational Study Investigators. The relationship between obesity and b-type natriuretic peptide levels. Arch Intern Med 2004;164:2247-52.
43. Mehra M.R., Uber P.A., Park M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (2004) 1590-1595
44. Krauser D.G., Lloyd-Jones D.M., Chae C.U., et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a proBNP investigation of dyspnea in the emergency department (PRIDE) substudy. Am Heart J 149 4 (2005) 744-750
45. Daniels L.B., Bhalla V., Clopton P., et al. B-type natriuretic peptide (BNP) levels and ethnic disparities in perceived severity of heart failure: results from the rapid emergency department heart failure outpatient trial (REDHOT) multicenter study of BNP levels and emergency department decision making in patients presenting with shortness of breath. J Card Fail 12 (2006) 281-285
46. Mueller C., Laule-Kilian K., Frana B., et al. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea. J Intern Med 258 (2005) 77-85
47. Weber M., and Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 92 (2006) 843-849
48. Mueller C., Laule-Kilian K., Scholer A., et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am J Cardiol 94 (2004) 1510-1514
49. Dries D.L., Exner D.V., Domanski M.J., et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
50. Heywood J.T., Fonarow G.C., Costanzo M.R., et al., ADHERE Scientific Advisory Committee and Investigators. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the adhere database. J Card Fail 13 (2007) 422-430
51. Akiba T., Tachibana K., Togashi K., et al. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 44 Suppl 1 (1995) S61-S64
52. Heeschen C., Hamm C.W., Mitrovic V., et al. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Diagnostic accuracy of b type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91 (2005) 606-612
53. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2 Suppl 1 (2002) S46-S75
54. Shapiro M., Moyers B., Marcus G.M., et al. Diagnostic characteristics of combining phonocardiographic third heart sound and systolic time intervals for the prediction of left ventricular dysfunction. J Card Fail 13 (2007) 18-24
55. Peacock W.F., Harrison A., and Moffa D. Clinical and economic benefits of using audicor s3 detection for diagnosis and treatment of acute decompensated heart failure. Congest Heart Fail 12 Suppl 1 (2006) 32-36
56. Packer M., Abraham W.T., Mehra M.R., et al. Prospective evaluation and identification of cardiac decompensation by icg test (predict) study investigators and coordinators utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 47 (2006) 2245-2252
57. Peacock W.F., Summers R.L., Vogel J., et al. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ed-impact trial. Acad Emerg Med 13 (2006) 365-371
58. Yamokoski L.M., Haas G.J., Gans B., et al. Optivol fluid status monitoring with an implantable cardiac device: a heart failure management system. Expert Rev Med Devices 4 (2007) 775-780
59. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 (2005) 841-848
60. Wang L. Fundamentals of intrathoracic impedance monitoring in heart failure. Am J Cardiol 99 (2007) 3G-10G
61. Vollmann D., Nägele H., Schauerte P., et al., European INSYNC Sentry Observational Study Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 28 (2007) 1835-1840
62. Kuwabara Y., Sato Y., Miyamoto T., et al. Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J 71 (2007) 1047-1051
63. Heeschen C., Hamm C.W., Mitrovic V., et al. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
64. You J.J., Austin P.C., Alter D.A., et al. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 153 (2007) 462-470
65. Sato Y., Kita T., Takatsu Y., et al. Biochemical markers of myocyte injury in heart failure. Heart 90 (2004) 1110-1113
66. Ishii J., Nomura M., Nakamura Y., et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89 (2002) 691-695
67. Fonarow G.C., Peacock W.F., Phillips C.O., et al., ADHERE Scientific Advisory Committee and Investigators. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 101 (2008) 231-237
68. Fonarow G.C., Peacock W.F., Phillips C.O., et al., ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 1943-1950
69. Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
70. Demir M., Kanadasi M., Akpinar O., et al. Cardiac troponin T as a prognostic marker in patients with heart failure: a 3-year outcome study. Angiology 58 (2007) 603-609